Prof. PeptideProf. Peptide

Everything you need for peptide research, in one place

73

Peptide profiles

75

Compounds compared

258

Verified discount codes

100%

Independent research

Certificates lab-checked in the last 7 days, as of November 22, 2026: NexPept, SPX Labs, Inno Aminos and 2 more.

Prof. Peptide provides peptide research for educational purposes only. Nothing on this site constitutes medical advice or endorses human use of research peptides.

Everything a researcher needs

From peptide mechanisms to reconstitution math — Prof. Peptide covers it all, clearly and credibly.

Latest News

View all news

November 22, 2026

Eloralintide Plus Tirzepatide (EloraTZP): 23.3% Weight Loss vs 14.8% on Tirzepatide Alone in Phase 2

Lilly's phase 2b trial of EloraTZP (eloralintide, an investigational amylin agonist, with tirzepatide) in 367 adults with obesity or overweight and type 2 diabetes: up to 23.3% weight loss at 48 weeks (eloralintide 9 mg + tirzepatide 15 mg) vs 14.8% on tirzepatide 15 mg and 3.0% on placebo, with more GI side effects and 10.8% to 27.0% stopping for adverse events on the combination. Company-reported; new participant reports at ObesityWeek.

Read more →

November 22, 2026

Australia's TGA Tests Seized KLOW, BPC-157/TB-500 and Retatrutide Vials: No TB-500 Found

The TGA's November 5, 2026 advisory: its laboratory found no detectable TB-500 in Synedica "KLOW 80 mg", "BARBIE KLOW 100 mg" and "BPC 157 & TB 500 10 mg", and less retatrutide than labeled in Synedica "Retatrutide 10 mg", with significant variation between samples. The findings cover the tested Synedica products, seized with NSW Police.

Read more →

November 19, 2026

Thymosin Beta-4 Eye Drop RGN-259 Misses Its Primary Endpoint in a Third Phase 3 Trial

SEER-2, a phase 3 trial of RGN-259 (thymosin beta-4 eye drops) for neurotrophic keratopathy at 50 sites, did not reach statistical significance on complete healing at 4 weeks, its sponsor reported in November 2026; no rates are published yet. None of the eye drop's three phase 3 trials has met its primary endpoint, and the results say nothing about injected TB-500.

Read more →
Why Prof. Peptide

Built for researchers

Most peptide sites exist to sell products. Prof. Peptide exists to educate. We're independent, ad-light, and committed to presenting research accurately — including limitations and unknowns.

  • ✓Content is editorially independent and research-driven
  • ✓Every peptide profile cites primary research literature
  • ✓Calculator math is transparent and peer-reviewable
  • ✓Discount codes are manually verified before publishing

Now on iOS

The all-in-one peptide tracker

Log doses, see estimated levels, calculate reconstitution, and search 70+ peptides by name or brand — all in one private iOS app.

Get the App

Don't overpay for peptides.

Prof. Peptide finds the best deals and delivers them to your inbox.